Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 672

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 672
---
Purchased 10,259,133 36,064
Vested ( 11,154,360) ( 42,127)
As at December 31, 2024 16,717,458 60,924
Based on the estimated achievement of performance conditions for 2024 financial year LTIP awards, the determined monetary amount was US$3,306,000which is recognized to share-based compensation expense over their requisite vesting period.
For the years ended December 31, 2024 and 2023, US$12,632,000and US$7,332,000of the LTIP awards were forfeited respectively based on the determined or estimated monetary amount as at the forfeiture date.

F-34

Table of Contents

The following table presents the share-based compensation expenses recognized under the LTIP awards:

                                                Year Ended December 31,                          
                                                                   2024        2023        2022  
 ─────────────────────────────────────────────────────────────────────────────────────────────────
                                                         (in US$ ’ 000)                          
  Research and development expenses                              12,098      18,224      16,101  
  Selling and administrative expenses                             6,028      11,690       7,376  
  Cost of revenue                                                   414         502         373  
                                                                 18,540      30,416      23,850  
  Recorded with a corresponding credit to:                                                       
  Liability                                                       3,710      11,364       6,216  
  Additional paid-in capital                                     14,830      19,052      17,634  
                                                                 18,540      30,416      23,850  

For the years ended December 31, 2024, 2023 and 2022, US$12,424,000, US$4,563,000and US$15,351,000were reclassified from liability to additional paid-in capital respectively upon LTIP awards reaching the determination date. As at December 31, 2024 and 2023, US$1,443,000and US$10,502,000were recorded in liabilities respectively.

As at December 31, 2024, the total unrecognized compensation cost was approximately US$21,469,000, which considers expected performance targets and the amounts expected to vest, and will be recognized over the requisite periods.

19. Revenue

The following table presents revenue disaggregated by contract